Industry News

Joslin receives $24.3 million grant from the NIH for diabetic kidney disease study Joslin Diabetes Center
Dance Biopharm Announces Joint Venture with Harmony Asset for the Development of Inhaled Insulin in Multiple Countries in Asia --Joint Venture Enables Dance Biopharm to Expedite Regulatory and Commercialization Efforts in China--
Savient Pharmaceuticals Commences Voluntary Chapter 11 Proceeding; Seeks To Conduct Auction And Sale Under Section 363 Enters into "Stalking Horse" Sale Agreement with US WorldMeds, LLCKRYSTEXXA® Remains Commercially Available in United States
Francisco Partners to Acquire McKesson’s Automation Unit
Abbott: New Study Reports Oral Nutritional Supplement Use in Pediatric Patients is Associated with Decreases in Length of Hospital Stay, Costs
Sanofi's Nasacort Allergy 24HR Receives FDA Approval for Over-the- Counter Use
EMD Serono Receives FDA Approval for Redesigned Fertility Pen
Pfizer Receives European Approval For Label Update Regarding The Use Of Prevenar 13 In Certain High-Risk Populations
Only One in Five People Consistently Recycles Packaging from Products Used in the Bathroom Johnson & Johnson Family of Consumer Companies Launches First Recycling Campaign on Tumblr to Remind Americans They Can Recycle in the Bathroom
Integra LifeSciences Announces Launch of Integra(R) Proximal Humeral Fracture Plate System in United States Offers Surgeons Versatile Solution for Shoulder Fracture Treatment
Overhauling confusing prescription medicine labels Northwestern University
Valeant Pharmaceuticals' Bausch + Lomb Gets U.S. FDA Clearance for Novel Monthly Disposable Contact Lens
Genzyme to Invest $80 Million in Framingham, Mass. Site to Expand Manufacturing Capacity for Fabrazyme®
St. Jude Medical Announces Acquisition and CE Mark Approval of World's First Leadless Pacemaker
Francisco Partners to Acquire McKesson’s Automation Unit
Abbott: New Study Reports Oral Nutritional Supplement Use in Pediatric Patients is Associated with Decreases in Length of Hospital Stay, Costs
Sanofi's Nasacort Allergy 24HR Receives FDA Approval for Over-the- Counter Use
Bayer HealthCare Celebrates Opening of State-of-the Art U.S. Headquarters in Whippany Largest Employer in Hanover Township represents $250 Million Dollar Investment in New Jersey
PharmaSmart® and Rexall Announce Breakthrough in Medication Therapy Management
MannKind Resubmits New Drug Application to U.S. FDA for AFREZZA for the Treatment of Adults with Diabetes
Genentech Announces Plans to Expand California Biologics Manufacturing Facilities
OTREXUP™ (methotrexate) Injection Approved By FDA a New Treatment for Adults with Rheumatoid Arthritis, Children with Polyarticular Idiopathic Arthritis, and Adults with Psoriasis
Genzyme to Invest $80 Million in Framingham, Mass. Site to Expand Manufacturing Capacity for Fabrazyme®
St. Jude Medical Announces Acquisition and CE Mark Approval of World's First Leadless Pacemaker
Arena Pharmaceuticals Reports That Eisai Will Double BELVIQ® (lorcaserin HCl) CIV Sales Force by December Expansion to Approximately 400 Sales Specialists Follows Increased Coverage of BELVIQ by Health Plans and Pharmacy Benefit Managers